Data from MAVERICK-HCM Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy Selected for Virtual Late-Breaker Presentation at the American College of Cardiology's 69th Annual Scientific Session Together with World Congress of Cardiology

Author's Avatar
Mar 20, 2020
Article's Main Image

Virtual Analyst and Investor Event to Review Data Planned for 4:30 p.m. EDT on March 30